Nordic Life Science Days 2018

VarCT Diagnostics/VAR2 Pharmaceuticals will be at the Nordic Life Science Days in Stockholm 10-12 September 2018. We look forward to meet old and new partners in the Life Science business.

Continue reading

A Proof-of-Concept study of VarCT Diagnostics’ technology for cancer diagnostics has been published in Nature Communications

Today a ground-breaking article demonstrating the potential of rVAR2-based isolation of Circulating Tumour Cells for diagnosis of multiple types of cancer was published in Nature Communications. The current methods for CTCs isolation are limited by insufficient specificity and sensitivity, which ha......
Continue reading

VarCT Diagnostics featured in MedWatch.dk

Check out the article about VarCT Diagnostics and VAR2 Pharmaceuticals (in Danish) here

 

Continue reading

BIO International Convention 2018

On Monday 3rd June to Thursday 7th June, Cheif Operating Officer Andreas Linderoth Norlin, will attend the BIO International Convention in Boston, MA. It will be four days of exciting meetings to explore new opportunities for collaborations and partnerships in the field of cancer diagnosti......
Continue reading

VarCT Diagnostics presenting at the ISMRC 2018 Congress

VarCT's Director of Discovery and Preclinical Development, Dr. Mette Ørskov Agerbæk, are to present new exciting data on capturing of CTCs at the 11th International Symposium on Minimal Residual Cancer in Montpellier, France. The poster, entitled "The rVAR2 malaria protein effici......
Continue reading